"Right to Try" Could Weigh Patients Down With Costs
Should Congress find a way forward for a proposal to expedite access to experimental drugs, patients could be stuck with big bills and the loss of hospice care eligibility.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.
